FIELD: medicine.
SUBSTANCE: invention refers to medicine and may be used for preventing and treating the diseases wherein endogenous production of cytokines and hemopoietins is advisable to be stimulated. What is presented is a method for stimulating endogenous production of cytokines and hemopoietins which is based on introducing a preparation presenting a double-stranded genomic sonicated human DNA of fragment size 200-6000 base pairs into the patient's body. The preparation is used in the tableted form in the number of 3 tablets containing 5 mg of the active substance of the preparation daily for 1-14 days.
EFFECT: invention provides more effective stimulation.
1 cl, 21 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING ONCOLOGICAL DISEASES | 2018 |
|
RU2675233C1 |
| METHOD OF TREATING ONCOLOGICAL DISEASES | 2012 |
|
RU2490028C1 |
| AGENT HAVING IMMUNOMODULATORY ACTIVITY | 2018 |
|
RU2697526C1 |
| METHOD OF MODIFICATION OF PERIPHERAL BLOOD MONOCYTES TO INCREASE THEIR PARACRINE ACTIVITY DURING AUTOLOGOUS TRANSPLANTATION | 2012 |
|
RU2497947C1 |
| PHARMACEUTICAL COMPOSITION WITH CYTOKINE AND IMMUNOMODULATING EFFECTS | 2002 |
|
RU2222345C2 |
| MEANS OF IMMUNOMODULATING ACTIVITY | 2017 |
|
RU2657819C1 |
| SUBSTANCE POSSESSING ANTI-INFLAMMATORY, IMMUNOMODULATING AND WOUND-HEALING ACTIVITY | 2005 |
|
RU2300384C2 |
| METHOD FOR PREPARING AUTOLOGOUS TUBERCULOSIS VACCINE | 2008 |
|
RU2372936C1 |
| METHOD OF EVALUATING IMMUNOGENECITY OF ANTI-BRICELLOSIS VACCINE STRAINS | 2009 |
|
RU2419096C2 |
| IMMUNOMODULATING HUMIC AGENT | 2020 |
|
RU2756353C1 |
